Drug intelligence / Profile preview

resveratrol + alpha lipoic acid + super oxide dismutase

Development stage
Phase 2
Lead developer
GSK
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

This is a combination dietary supplement containing three antioxidant compounds—resveratrol, alpha lipoic acid, and superoxide dismutase. Each component acts as an antioxidant but through different mechanisms: - **Resveratrol** is a polyphenolic compound found in grapes and berries, known for its ability to modulate Sirtuin 1/3 activity, improve mitochondrial function, and reduce oxidative stress. - **Alpha lipoic acid** is both water- and fat-soluble, functioning as a cofactor in mitochondrial energy metabolism and directly scavenging reactive oxygen species. It also helps regenerate other antioxidants. - **Superoxide dismutase (SOD)** is an endogenous enzyme that catalyzes the conversion of superoxide radicals into hydrogen peroxide and oxygen, providing cellular protection from oxidative damage. The combination has been studied primarily for its potential benefits in conditions associated with oxidative stress such as diabetic neuropathy[2], sciatica due to herniated discs[1], myocardial ischemia-reperfusion injury[4], and radiation-induced tissue injury[5]. The rationale behind combining these agents lies in their complementary mechanisms targeting multiple pathways of oxidative damage.

02

Targets

SIRT1 (NAD-dependent protein deacetylase sirtuin-1)SIRT3 (NAD-dependent protein deacetylase sirtuin-3)Misfolded SOD1

Beyond the preview

Go deeper on resveratrol + alpha lipoic acid + super oxide dismutase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on resveratrol + alpha lipoic acid + super oxide dismutase.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call